Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories. The company was founded in 1989 and is based in Salt Lake City, Utah.
Frequently asked questions
What sector does Paradigm Medical Ind (PDMI) operate in?
Paradigm Medical Ind belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Paradigm Medical Ind (PDMI) current stock price?
As of the latest data, Paradigm Medical Ind stock price is $0.00, with a previous close of $0.00.
What is Paradigm Medical Ind (PDMI) current market capitalization?
Paradigm Medical Ind market cap is approximately 324.88 thousand.
Does Paradigm Medical Ind (PDMI) pay dividends?
No. Paradigm Medical Ind does not pay a dividend.
What is Paradigm Medical Ind (PDMI) beta (volatility) score?
Paradigm Medical Ind has a beta of -98.933, indicating lower volatility than the overall market.